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Abstract 
Hematopoietic stem cell transplantation (HSCT) is a curative treatment for a wide range 
of malignant and hereditary disorders. It is yet the only clinically established stem cell 
treatment. Hematopoietic stem and progenitor cells (HSPC) can be harvested from bone 
marrow (BM), stimulated peripheral blood (PBSC) or umbilical cord blood (CB) col-
lected from the placenta after clamping of the cord. A critical factor for the success of 
HSCT is the dose of functioning HSPC the recipient receives. The National Swedish 
Cord Blood Bank (NSCBB) was founded in 2005. We compiled the achievements of 
the NSCBB and investigated the impact of a change of practices from early to delayed 
clamping on CB collection volume and nucleated cell number. We developed novel 
methods using flow cytometry for measurement of functional HSPC in CB, firstly for 
the simultaneous definition of the Hoechst Side Population (SP), Aldehyde Dehydro-
genase activity (ALDH) and the expression of the surface protein CD34 and secondly 
for the definition of viable and apoptotic cells in the ALDH and CD34 positive popula-
tions respectively. Finally, we screened for biomarkers in CB plasma that may predict 
the HSPC content in the corresponding CB collection using a multiplex immunoassay. 
The NSCBB stands up well in international comparison and the implementation of de-
layed clamping had no major effect on collection efficiency. There was no overlap be-
tween the SP and the ALDH populations, suggesting that they define HSPC pools with 
different properties. Few apoptotic cells were identified in the ALDH population com-
pared to the viable CD34 positive population, indicating that the ALDH assay intrinsi-
cally excludes apoptotic cells. We identified the CDCP-1 protein as a possible bi-
omarker for HSPC content in CB. 
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